Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia

Emerg Infect Dis. 2017 Jan;23(1):162-164. doi: 10.3201/eid2301.161497.

Abstract

Candida auris is an emerging multidrug-resistant fungus that causes a wide range of symptoms. We report finding 17 cases of C. auris infection that were originally misclassified but correctly identified 27.5 days later on average. Patients with a delayed diagnosis of C. auris had a 30-day mortality rate of 35.2%.

Keywords: Americas; Candida auris; Colombia; Etest; VITEK; antimicrobial resistance; candidemia; fungemia; fungi.

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antifungal Agents / therapeutic use
  • Candida / chemistry
  • Candida / drug effects
  • Candida / isolation & purification
  • Candida / pathogenicity*
  • Candidiasis, Invasive / diagnosis*
  • Candidiasis, Invasive / drug therapy
  • Candidiasis, Invasive / microbiology
  • Candidiasis, Invasive / mortality
  • Child
  • Child, Preschool
  • Colombia
  • Delayed Diagnosis
  • Drug Resistance, Multiple, Fungal*
  • Female
  • Fungemia / diagnosis*
  • Fungemia / drug therapy
  • Fungemia / microbiology
  • Fungemia / mortality
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Survival Analysis

Substances

  • Antifungal Agents